ReviewJournal of Cancer2022

FSCN1 acts as a promising therapeutic target in the blockade of tumor cell motility: a review of its function, mechanism, and clinical significance.

Zhongxun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.